Retina International have launched a survey for people receiving anti-VEGF therapy for Age-related Macular Degeneration (AMD) or Diabetes-related Macular Edema (DME).
This survey, which is now available in German, as well as English, aims to gather the opinion of people receiving eye injections for wet AMD, DME, and the opinion of their carers. If you belong to one of these groups of people, your opinion is critical to assess the barriers to optimum care.
These surveys assess your perception of the care pathway prior to any COVID-19 interruptions, and currently as a direct result of any COVID-19 interruptions.
All responses to these surveys are anonymous and your privacy will be protected in line with GDPR guidelines.
If you are receiving AMD or DME injection therapy or if you are a caregiver to someone receiving AMD or DME injection therapy in the USA, UK or Germany, we encourage you to participate in this survey. Your involvement is greatly appreciated!
Alternatively, if you know someone who is eligible to participate, please share this survey with them.
The survey is available to those living in the UK, USA and Germany and depending on whether you receive AMD or DME injection therapy or care for someone either receiving AMD or DME injection therapy, you will participate in one of four surveys:
Survey 1: Neovascular (Wet) Age-related Macular Degeneration Patient Survey.
This survey is for people receiving AMD injection therapy and is expected to take 22 minutes to complete (May take longer if using a screen reader).
Neovascular Age-related Macular Degeneration Patient Survey.
Patienten-Umfrage zu neovaskulärer (feuchter) altersbedingter Makuladegeneration.
Survey 2: Neovascular (Wet) Age-related Macular Degeneration Caregiver Survey.
This survey is for the caregiver to someone receiving AMD injection therapy and is expected to take 19 minutes to complete (May take longer if using a screen reader).
Neovascular Age-related Macular Degeneration Caregiver Survey.
Pflegekraft-Umfrage zu feuchter altersbedingter Makuladegeneration (feuchte AMD)
Survey 3: Diabetes-related Macular Edema Patient Survey.
This survey is for people receiving DME injection therapy and is expected to take 23 minutes to complete (May take longer if using a screen reader).
Diabetes-related Macular Edema Patient Survey.
Survey 4: Diabetes-related Macular Edema Caregiver Survey.
This survey is for the caregiver to someone receiving DME injection therapy and is expected to take 19 minutes to complete (May take longer if using a screen reader).
Diabetes-related Macular Edema Caregiver Survey.
Pflegekraft-Umfrage zum diabetischen Makulaödem (DMÖ).